Clinical Trial Update: Study of BB-031 in Acute Ischemic Stroke Patients (RAISE) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial (RAISE) evaluating BB-031 in patients with acute ischemic stroke is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• BB-031

Snippet

Sponsor: Basking Biosciences, Inc. | Conditions: Acute Ischemic Stroke | Phase 2 | Status: RECRUITING